FDA Contracts For QRA Model To Determine Safe Use Levels For 26 Fragrance Allergens

The ingredients at issue already must be labeled on cosmetic products in the EU due to their recognized sensitization and allergy potential. FDA expects to award the contract by the end of September, and finished work will be due to the agency within 18 months thereafter.